Answer
Yes, Faslodex (fulvestrant) is contraindicated in patients with severe hepatic impairment.
Sources for this answer
- Faslodex 250 mg solution for injectionAstraZeneca UK Limited · emc · SmPC §4.3 Contraindications · Version 28Document updated
Sources checked